BREXIN

This brand name is authorized in Albania, Brazil, Cyprus, Estonia, France, Israel, Italy, Lithuania, Singapore.

Active ingredients

The drug BREXIN contains one active pharmaceutical ingredient (API):

1	Piroxicam beta-cyclodextrin UNII 13T4O6VMAM - PIROXICAM
	Piroxicam is a non-steroidal anti-inflammatory agent with analgesic and antipyretic activity. It is effective regardless of the aetiology of the inflammation.
	Read more about Piroxicam

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
M01AC01	Piroxicam	M Musculo-skeletal system → M01 Antiinflammatory and antirheumatic products → M01A Antiinflammatory and antirheumatic products, non-steroids → M01AC Oxicams
Discover more medicines within M01AC01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
AL	Fondi i Sigurimit të Detyrueshëm të Kujdesit Shëndetësor	220/370
BR	Câmara de Regulação do Mercado de Medicamentos	517700303118410
EE	Ravimiamet	1039889, 1039890
FR	Base de données publique des médicaments	67229344, 68626690
IL	מִשְׂרַד הַבְּרִיאוּת	6027, 6366, 6367
IT	Agenzia del Farmaco	026446056, 026446106
LT	Valstybinė vaistų kontrolės tarnyba	1004779, 1015187, 1080180, 1085611, 1085612, 1086011, 1086012
SG	Health Sciences Authority	07791P